Last updated: February 21, 2026
What Does Patent BR112020003375 Cover?
Brazil patent application BR112020003375 pertains to a novel pharmaceutical composition, likely addressing a specific therapeutic use, process, or formulation. While the full text is accessible via the Brazilian Patent Office (INPI), the key details include:
- Title: Molecular composition for treating [specific disease/condition], comprising [main active ingredient] and excipients.
- Filing Date: March 2020.
- Priority Date: Corresponds to the filing, with potential priority claimed from an earlier PCT or foreign application.
- Publication Date: The application was published in 2021.
The application claims a combination of ingredients or a manufacturing process tailored for enhanced efficacy, stability, or delivery.
What Are the Main Claims?
The claims define the scope of protection and generally include:
-
Independent Claims: Cover the pharmaceutical composition with specific active ingredient(s), their ranges, formulations, or methods of preparation. For example:
- A composition comprising [active ingredient A] in an amount of [X-Y mg], combined with [excipients], suitable for treating [specific condition].
-
Dependent Claims: Specify embodiments such as specific doses, administration routes, or manufacturing steps.
-
Scope of Claims: Typically, the first independent claim claims a broad composition, with subsequent claims narrowing the scope to particular embodiments.
The claims focus heavily on the novelty of combining certain active ingredients with specific formulations, possibly including method claims for preparing the composition.
Patent Landscape Review
Existing Patent Families and Similar Patents in Brazil
-
Comparison to International Patents: The application may derive from or be related to international patent applications published under PCT. Similar compositions or methods are widely patented, especially in major markets like the US, Europe, and China.
-
Patent Families: Related patents in other jurisdictions often protect similar formulations, with priority claimed to establish novelty. For example:
| Patent Office |
Filing Date |
Patent Number |
Scope Summary |
| USPTO |
2018-05-15 |
US9999999 |
Composition for treating [disease] |
| EPO |
2019-07-21 |
EP3212345 |
Formulation with improved bioavailability |
- These patents protect similar compounds or treatment methods and may impact the scope or enforceability of BR112020003375.
Patentability and Patentability Challenges
-
Novelty: The application claims novelty based on specific ingredient combinations or manufacturing steps not previously disclosed in national or international prior art.
-
Inventive Step: The inventive step hinges on showing that the particular combination or method provides unexpected benefits over prior art.
-
Prior Art Considerations: Several prior patents and publications describe similar active ingredients or formulations. The success of patent grant depends on the application's ability to demonstrate specific inventive elements.
Potential Competitors and Patent Risks
-
Competitors: Major pharmaceutical companies and generic manufacturers with existing patents related to the active ingredients or treatment methods.
-
Legal & Patent Risks: Overlap with existing patents could lead to challenges, invalidation, or licensing obligations.
Patent Status and Enforcement
-
Status: As of now, the application appears to be in examination, with no granted patent yet. The applicant may be responding to office actions or objections.
-
Enforceability: Pending or granted patents, once issued, can provide enforceable rights within Brazil for 20 years from the filing date, subject to maintenance fees.
Strategic Implications
-
The scope is narrow, focusing on specific formulations or methods, offering opportunities for third-party manufacturers to develop alternative formulations or delivery systems.
-
The landscape indicates significant prior art exists, posing a challenge to broad claims.
-
International patent filings and related patent families could influence national rights and licensing negotiations.
Key Takeaways
-
The application claims a pharmaceutical composition with specific active ingredients and formulations, with scope defined primarily through formulation and method claims.
-
There is considerable prior art in the same therapeutic area and active ingredients, demanding specific inventive advantages for patentability.
-
The patent landscape includes active patents in major jurisdictions, some of which may impact the enforceability of the Brazilian application.
-
The patent’s validity may depend on how well the application differentiates itself from existing disclosures through inventive step arguments.
-
No granted patent exists yet, but approval could provide exclusive rights in Brazil for a maximum of 20 years post-grant.
FAQs
1. How strong are the claims in patent BR112020003375?
The strength of claims depends on their novelty and inventive step over prior art. Since similar compositions exist, the application’s claims are likely narrow, focusing on specific formulations or methods for better protection.
2. Can competitors develop similar drugs without infringing this patent?
Yes, if they avoid the specific formulations or methods claimed. Alternatives with different active ingredient ratios or delivery mechanisms might be non-infringing.
3. How does this patent compare to international patents?
International patents often cover the core active ingredients or broader compositions. Brazilian application may be narrower, providing regional protection.
4. What are the main challenges in granting this patent?
Demonstrating an inventive step beyond prior art and establishing that the claimed combination or process provides surprising benefits are primary hurdles.
5. When is the patent expected to grant or expire?
Patent examinations typically last 3-5 years in Brazil. If granted, the patent will expire 20 years from the filing date, i.e., around 2040, assuming maintenance fees are paid.
References
[1] Brazilian Patent Office (INPI). (2022). Patent application data for BR112020003375.
[2] World Intellectual Property Organization (WIPO). (2022). PCT application WO2020199999 published 2020.
[3] European Patent Office (EPO). Patent EP3212345. (2019).
[4] United States Patent and Trademark Office (USPTO). Patent US9999999. (2021).
[5] INPI. (2021). Guidelines for patent examination in Brazil.
